Related Experiment Video

Updated: Mar 24, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

344

MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1

Shilian Zhang1, Yuehua Zhao1, Lijie Wang1

  • 1Department of Pediatrics, Affiliated Hospital of Weifang Medical University, China.

Biochemical and Biophysical Research Communications
|March 13, 2016
PubMed

Insights

MicroRNA-198 (miR-198) is downregulated in osteosarcoma, suppressing tumor growth and metastasis. This microRNA shows potential as a diagnostic marker and therapeutic target for osteosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) is an aggressive bone cancer with poor prognosis, often leading to relapse or metastasis.
  • MicroRNAs (miRNAs) offer new avenues for early diagnosis and treatment of OS.
  • Understanding specific miRNA roles, like miR-198, is crucial for advancing OS therapy.

Purpose of the Study:

  • To investigate the expression profile of microRNA-198 (miR-198) in osteosarcoma.
  • To elucidate the functional role of miR-198 in osteosarcoma cell proliferation, migration, and invasion.
  • To identify potential molecular targets of miR-198 in osteosarcoma.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess miR-198 expression in osteosarcoma tissues and cell lines.
  • In vitro assays including cell proliferation, migration, and invasion assays following miR-198 mimic transfection.
  • Bioinformatic analysis and experimental validation to identify direct targets of miR-198.

Main Results:

  • miR-198 expression was significantly lower in osteosarcoma tissues and cell lines compared to normal controls.
  • Reduced miR-198 levels correlated with advanced TNM stage and distant metastasis in osteosarcoma patients.
  • Transfection with miR-198 mimics suppressed osteosarcoma cell proliferation, migration, and invasion.
  • ROCK1 was identified as a direct target gene regulated by miR-198 in osteosarcoma.

Conclusions:

  • miR-198 functions as a tumor suppressor in osteosarcoma.
  • miR-198 may serve as a valuable prognostic biomarker for osteosarcoma.
  • Targeting miR-198 presents a potential strategy for molecular therapy in osteosarcoma treatment.
Keywords:
GrowthMetastasisOsteosarcomaROCK1microRNA-198

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K